CD47 protein expression, calculated as the percentage of tumor cells expressing CD47, has modest difference across the molecular subgroups (Figure 5A); the CMS1 CRC subtype demonstrated a statistically significant but subtle increase in CD47 expression compared to CMS3. The gene discussed is CD47; the disease is neoplasm.